Erika M. Kwon

4.0k total citations
48 papers, 1.9k citations indexed

About

Erika M. Kwon is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Erika M. Kwon has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 19 papers in Genetics. Recurrent topics in Erika M. Kwon's work include Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Genetic Associations and Epidemiology (8 papers). Erika M. Kwon is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Genetic Associations and Epidemiology (8 papers). Erika M. Kwon collaborates with scholars based in United States, South Africa and United Kingdom. Erika M. Kwon's co-authors include Elaine A. Ostrander, Janet L. Stanford, Liesel M. FitzGerald, Ziding Feng, Joseph S. Koopmeiners, Claudia A. Salinas, Janet L. Stanford, Daniel W. Lin, Sarah K. Holt and Ilir Agalliu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Erika M. Kwon

45 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika M. Kwon United States 25 800 729 522 388 316 48 1.9k
Daniel Ford United Kingdom 16 410 0.5× 616 0.8× 1.2k 2.3× 419 1.1× 441 1.4× 39 2.2k
Damien Ambrosetti France 26 574 0.7× 867 1.2× 294 0.6× 368 0.9× 124 0.4× 90 2.3k
Manuel Sánchez‐Chapado Spain 24 646 0.8× 560 0.8× 154 0.3× 238 0.6× 219 0.7× 94 1.7k
Ilona N. Holcomb United States 12 239 0.3× 693 1.0× 181 0.3× 306 0.8× 87 0.3× 19 1.5k
Gang‐Hong Lee Japan 24 419 0.5× 869 1.2× 237 0.5× 341 0.9× 237 0.8× 104 1.8k
Jay D. Hunt United States 25 594 0.7× 997 1.4× 200 0.4× 405 1.0× 249 0.8× 49 2.0k
Tamar Rubinek Israel 23 206 0.3× 671 0.9× 638 1.2× 233 0.6× 75 0.2× 50 1.6k
Catherine Lofton–Day United States 20 572 0.7× 1.5k 2.1× 229 0.4× 1.1k 2.8× 1.0k 3.3× 32 3.6k
Hirokazu Taniguchi Japan 23 382 0.5× 596 0.8× 80 0.2× 225 0.6× 136 0.4× 109 1.6k
Siqun L. Zheng United States 36 1.4k 1.7× 1.4k 2.0× 1.2k 2.3× 724 1.9× 324 1.0× 79 3.9k

Countries citing papers authored by Erika M. Kwon

Since Specialization
Citations

This map shows the geographic impact of Erika M. Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika M. Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika M. Kwon more than expected).

Fields of papers citing papers by Erika M. Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika M. Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika M. Kwon. The network helps show where Erika M. Kwon may publish in the future.

Co-authorship network of co-authors of Erika M. Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Erika M. Kwon. A scholar is included among the top collaborators of Erika M. Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika M. Kwon. Erika M. Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhen, Tao, Erika M. Kwon, Ling Zhao, et al.. (2017). Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11. Blood. 130(22). 2431–2442. 20 indexed citations
3.
Decker, Brennan, Heidi G. Parker, Deepika Dhawan, et al.. (2015). Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer—Evidence for a Relevant Model System and Urine-Based Diagnostic Test. Molecular Cancer Research. 13(6). 993–1002. 100 indexed citations
4.
Connelly, Jon P., Erika M. Kwon, Yongxing Gao, et al.. (2014). Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects. Blood. 124(12). 1926–1930. 54 indexed citations
5.
Shearin, Abigail L., Benoît Hédan, Édouard Cadieu, et al.. (2012). The MTAP-CDKN2A Locus Confers Susceptibility to a Naturally Occurring Canine Cancer. Cancer Epidemiology Biomarkers & Prevention. 21(7). 1019–1027. 69 indexed citations
6.
Wu, Xinyan, Stephan Ellmann, Ethel Rubin, et al.. (2012). ADP Ribosylation by PARP-1 Suppresses HOXB7 Transcriptional Activity. PLoS ONE. 7(7). e40644–e40644. 15 indexed citations
7.
Kwon, Erika M., Sarah K. Holt, Rong Fu, et al.. (2012). Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk. Cancer Epidemiology. 36(4). 347–353. 38 indexed citations
8.
White, Thomas A., Erika M. Kwon, Rong Fu, et al.. (2012). The Monoamine Oxidase A gene promoter repeat and prostate cancer risk. The Prostate. 72(15). 1622–1627. 15 indexed citations
9.
Kwon, Erika M., Claudia A. Salinas, Suzanne Kolb, et al.. (2011). Genetic Polymorphisms in Inflammation Pathway Genes and Prostate Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 20(5). 923–933. 49 indexed citations
10.
Wright, Jonathan L., Erika M. Kwon, Elaine A. Ostrander, et al.. (2011). Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes. Cancer Epidemiology Biomarkers & Prevention. 20(4). 619–627. 120 indexed citations
11.
Lin, Daniel W., Liesel M. FitzGerald, Rong Fu, et al.. (2011). Genetic Variants in the LEPR , CRY1 , RNASEL , IL4 , and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality. Cancer Epidemiology Biomarkers & Prevention. 20(9). 1928–1936. 55 indexed citations
12.
Fesinmeyer, Megan D., Erika M. Kwon, Rong Fu, Elaine A. Ostrander, & Janet L. Stanford. (2011). Genetic variation in RNASEL and risk for prostate cancer in a population‐based case–control study. The Prostate. 71(14). 1538–1547. 11 indexed citations
13.
Langeberg, Wendy J., Erika M. Kwon, Joseph S. Koopmeiners, Elaine A. Ostrander, & Janet L. Stanford. (2010). Population-Based Study of the Association of Variants in Mismatch Repair Genes with Prostate Cancer Risk and Outcomes. Cancer Epidemiology Biomarkers & Prevention. 19(1). 258–264. 23 indexed citations
14.
Langeberg, Wendy J., Salahaldin A. Tahir, Ziding Feng, et al.. (2010). Association of caveolin‐1 and ‐2 genetic variants and post‐treatment serum caveolin‐1 with prostate cancer risk and outcomes. The Prostate. 70(9). 1020–1035. 13 indexed citations
15.
Salinas, Claudia A., Erika M. Kwon, Liesel M. FitzGerald, et al.. (2010). Use of Aspirin and Other Nonsteroidal Antiinflammatory Medications in Relation to Prostate Cancer Risk. American Journal of Epidemiology. 172(5). 578–590. 78 indexed citations
16.
Wright, Jonathan L., Erika M. Kwon, Daniel W. Lin, et al.. (2010). CYP17 polymorphisms and prostate cancer outcomes. The Prostate. 70(10). 1094–1101. 23 indexed citations
17.
Holt, Sarah K., Erika M. Kwon, Joseph S. Koopmeiners, et al.. (2010). Vitamin D pathway gene variants and prostate cancer prognosis. The Prostate. 70(13). 1448–1460. 67 indexed citations
18.
Agalliu, Ilir, Erika M. Kwon, Claudia A. Salinas, et al.. (2009). Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes & Control. 21(2). 289–300. 75 indexed citations
19.
Salinas, Claudia A., Joseph S. Koopmeiners, Erika M. Kwon, et al.. (2008). Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. The Prostate. 69(4). 363–372. 65 indexed citations
20.
Agalliu, Ilir, Erika M. Kwon, Laura McIntosh, et al.. (2007). Germline Mutations in theBRCA2Gene and Susceptibility to Hereditary Prostate Cancer. Clinical Cancer Research. 13(3). 839–843. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Ford Breakdown of academic impact, for papers by Damien Ambrosetti Breakdown of academic impact, for papers by Manuel Sánchez‐Chapado Breakdown of academic impact, for papers by Ilona N. Holcomb Breakdown of academic impact, for papers by Gang‐Hong Lee Breakdown of academic impact, for papers by Jay D. Hunt Breakdown of academic impact, for papers by Tamar Rubinek Breakdown of academic impact, for papers by Catherine Lofton–Day Breakdown of academic impact, for papers by Hirokazu Taniguchi Breakdown of academic impact, for papers by Siqun L. Zheng
Rankless by CCL
2026